BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 Study

Clinical trial NCT03639844 · NO_LONGER_AVAILABLE

Trial details

NCT number: NCT03639844
Sponsor: Bellicum Pharmaceuticals
Status: NO_LONGER_AVAILABLE
Study type: EXPANDED_ACCESS

Hurler Syndrome Inherited Metabolic Disorder Lysosomal Storage Disorder Metachromatic Leukodystrophy Inborn Errors of Metabolism

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.